Neil W. Peterson - 22 Aug 2023 Form 4 Insider Report for MERIT MEDICAL SYSTEMS INC (MMSI)

Role
CHIEF OPERATING OFFICER
Signature
/s/ Brian G. Lloyd, Attorney-in-Fact
Issuer symbol
MMSI
Transactions as of
22 Aug 2023
Net transactions value
-$317,688
Form type
4
Filing time
23 Aug 2023, 11:32:04 UTC
Previous filing
20 Mar 2023
Next filing
06 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MMSI Common Stock Options Exercise $225,600 +8,000 $28.20 8,000 22 Aug 2023 Direct
transaction MMSI Common Stock Sale $543,288 -8,000 -100% $67.91 0 22 Aug 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MMSI Non-qualified stock options (right to buy) Options Exercise $0 -8,000 -100% $0.000000* 0 22 Aug 2023 Common Stock 8,000 $28.20 Direct F2
holding MMSI Non-qualified stock options (right to buy) 15,000 22 Aug 2023 Common Stock 15,000 $44.80 Direct F3
holding MMSI Non-qualified stock options (right to buy) 20,000 22 Aug 2023 Common Stock 20,000 $54.40 Direct F4
holding MMSI Non-qualified stock options (right to buy) 25,000 22 Aug 2023 Common Stock 25,000 $68.33 Direct F5
holding MMSI Non-qualified stock options (right to buy) 13,576 22 Aug 2023 Common Stock 13,576 $70.58 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.79 to $68.05 inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F2 Becomes exercisable in equal annual installments of 20% commencing 4/14/2018.
F3 Becomes exercisable in equal annual installments of 20% commencing 3/2/2019.
F4 Becomes exercisable in equal annual installments of 20% commencing 4/25/2020.
F5 Becomes exercisable in equal annual installments of 25% commencing 8/19/2022.
F6 Becomes exercisable in equal annual installments of 25% commencing 2/28/2024.